๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Early and sustained clopidogrel therapy worth it in Europe

Book ID
120853085
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2005
Weight
142 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Switching cholinesterase inhibitor thera
Switching cholinesterase inhibitor therapy in Alzheimer's diseaseโ€”donepezil to rivastigmine, is it worth it?
โœ Roger Bullock; Claire Connolly ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 34 KB ๐Ÿ‘ 1 views

Switching from donepezil to rivastigmine was beneยฎcial in cognitive and global terms in 55.0% of the patients with Alzheimer's disease studied. \* Side-effects on donepezil and rivastigmine were independent of one another. \* It may be possible to extend the positive effects that cholinesterase inhi